Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Acumen Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get ABOS alerts

About Derek Meisner

Earlier roles on record: General Counsel at X4 Pharmaceuticals, Inc (XFOR) until August 22, 2022. The proxy statement of Acumen Pharmaceuticals, Inc. reports total compensation of $1,476,637 for Derek Meisner in fiscal 2023, including a base salary of $455,663. Disclosed compensation is on record for 4 fiscal years. Acumen Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acumen Pharmaceuticals, Inc. includes Daniel O'Connell (CEO), Dr. George Golumbeski (Chairman and Board Member), Matthew Zuga (CFO) and 2 others.

Affiliation history

Company network

Leadership on record at Acumen Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Acumen Pharmaceuticals, Inc. (ABOS) $455,663 $1,476,637
2022 Acumen Pharmaceuticals, Inc. (ABOS) $141,705 $1,279,668
2021 X4 Pharmaceuticals, Inc (XFOR) $428,173 $1,039,269
2020 X4 Pharmaceuticals, Inc (XFOR) $400,000 $1,112,800

Recent activity

No call appearances or filed executive changes recorded yet.